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Objectives The purpose of this study was to assess the impact of patient population characteristics on accuracy by com-
puted tomography angiography (CTA) to detect obstructive coronary artery disease (CAD).
Background The ability of CTA to exclude obstructive CAD in patients of different pre-test probabilities and in presence of cor-
onary calcification remains uncertain.
Methods For the CORE-64 (Coronary Artery Evaluation Using 64-Row Multidetector Computed Tomography Angiography) study,
371 patients underwent CTA and cardiac catheterization for the detection of obstructive CAD, defined as 50% lumi-
nal stenosis by quantitative coronary angiography (QCA). This analysis includes 80 initially excluded patients with a
calcium score 600. Area under the receiver-operating characteristic curve (AUC) was used to evaluate CTA diagnos-
tic accuracy compared to QCA in patients according to calcium score and pre-test probability of CAD.
Results Analysis of patient-based quantitative CTA accuracy revealed an AUC of 0.93 (95% confidence interval [CI]: 0.90
to 0.95). The AUC remained 0.93 (95% CI: 0.90 to 0.96) after excluding patients with known CAD but decreased
to 0.81 (95% CI: 0.71 to 0.89) in patients with calcium score 600 (p  0.077). While AUCs were similar (0.93,
0.92, and 0.93, respectively) for patients with intermediate, high pre-test probability for CAD, and known CAD,
negative predictive values were different: 0.90, 0.83, and 0.50, respectively. Negative predictive values de-
creased from 0.93 to 0.75 for patients with calcium score 100 or 100, respectively (p  0.053).
Conclusions Both pre-test probability for CAD and coronary calcium scoring should be considered before using CTA for exclud-
ing obstructive CAD. For that purpose, CTA is less effective in patients with calcium score 600 and in patients
with a high pre-test probability for obstructive CAD. (J Am Coll Cardiol 2012;59:379–87) © 2012 by the
American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.06.079Computed tomography coronary angiography (CTA) is an
emerging tool for the noninvasive assessment of coronary
artery disease (CAD). Several expert consensus documents
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Disease Prevalence Impacts CT Diagnostic Accuracy January 24, 2012:379–87endorse the use of CTA for ex-
cluding CAD in symptomatic
patients with reference to nu-
merous studies that have re-
ported high negative predictive
values (1,2). However, predictive
values heavily depend on disease
prevalence within the study pop-
ulation; thus, they cannot be ap-
plied outside the context of a
defined patient group (3–5). Ac-
cordingly, an assessment of pre-
test probability of CAD may
help predict the value of CTA for excluding or confirming
the presence of CAD. In this regard, coronary arterial
calcification detected by noncontrast CT correlates well
with CAD prevalence, and therefore may help to identify
patients in whom ruling out or confirming CAD by CTA is
of low yield. Furthermore, coronary arterial calcification
may also alter the diagnostic performance of CTA (6–9).
Coronary calcium substantially attenuates X-ray penetra-
tion, leading to “blooming” artifacts with current CT image
reconstruction that may obscure the coronary lumen. Be-
cause of the perceived limitation of CTA in patients with
severe coronary calcification, many investigators have fa-
vored obtaining a coronary calcium score to inform the
decision whether to proceed with CTA (10). However, the
utilization of a coronary calcium score threshold for decid-
ing to perform or not perform coronary CTA remains
controversial (11).
We have previously reported the diagnostic performance
of CTA among an international cohort of patients with a
calcium score of 600 (12). Including all enrolled patients
regardless of the presence and extent of coronary calcifica-
tion, this investigation tested the following hypotheses:
1) accuracy for CTA to detect obstructive CAD in patients
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CAD  coronary artery
disease
CI  confidence interval
CTA  computed
tomography angiography
QCA  quantitative
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Manuscript received February 11, 2011; revised manuscript received June 30, 2011,
accepted June 30, 2011.with severe coronary arterial calcification is reduced com-
pared to patients with low or moderate coronary calcifica-
tion; 2) predictive values for detecting obstructive CAD by
CTA are highly variable according to calcium scores and
disease prevalence in the study population; and 3) CTA is
ineffective for ruling out obstructive CAD in patients with
severe coronary arterial calcification and in patients with
high pre-test probability of CAD.
Methods
The study design has been described in detail previously
(13). In brief, the CORE-64 (Coronary Artery Evaluation
Using 64-Row Multidetector Computed Tomography An-
giography) study is a prospective, multicenter diagnostic
study performed at 9 hospitals in 7 countries designed to
evaluate the diagnostic accuracy of CTA for identifying
coronary artery stenosis in patients with suspected or known
significant CAD (12). All centers received study approval
from their local institutional review boards, and all patients
gave written informed consent.
Patient population. Eligible patients were at least 40 years
of age, had suspected symptomatic CAD, and were referred
for conventional coronary angiography. Patients were not
eligible if they had a history of cardiac surgery, allergy to
iodinated contrast material or contrast-induced nephropa-
thy, multiple myeloma, organ transplantation, elevated se-
rum creatinine level (1.5 mg/dl [133 mol/l]) or creati-
ine clearance 60 ml/min, atrial fibrillation, New York
eart Association functional class III or IV heart failure,
ortic stenosis, percutaneous coronary intervention within
he past 6 months, intolerance to beta-blockers, or a body
ass index 40. Patients with Agatston calcium scores of
600 were pre-specified to be excluded from the primary
nalysis of the study but were included for secondary
nalyses performed identically to the main cohort. The
ationale by the steering committee for excluding patients
ith calcium score600 was based on: 1) the precedence of
xcluding such patients in a prior multicenter study (14);
nd 2) the concern of futility of CTA imaging in such
atients based on the data available at the study design
lanning. This current investigation includes the results for
he primary CORE-64 study patient cohort and for patients
ith calcium score 600 who were not included in the
rimary analysis of the CORE-64 study (12).
cquisition and analysis of data from CT. Patients un-
erwent 2 CT scans (coronary calcium scoring and angiog-
aphy) before conventional coronary angiography was per-
ormed, using 64-row scanners with a slice thickness of 0.5
m (Aquilion 64, Toshiba Medical Systems, Tochigi-ken,
apan). Calcium scoring was performed with the use of
rospective electrocardiographic gating with 400-ms gantry
otation, 120-kV tube voltage, and 300-mA tube current.
or CTA, retrospective electrocardiographic gating was
sed, with heart rate adjusted gantry rotations of 350 ms to
00 ms to enable adaptive multisegmented reconstruction.
r
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by patients’ weight to ensure a sex-specific radiation dose of
12 to 15 mSv, with a maximum effective dose of 20 mSv, for
the combination of multidetector CT calcium scoring and
angiographic procedures. This was achieved by instituting a
cap of 270 mA for women and 400 mA for men. Sublingual
nitrates were given before CTA. Iopamidol (Isovue 370,
Bracco Imaging, Milan, Italy) was the intravenous contrast
medium used for CTA. Beta-blockers were given if the
resting heart rate was 70 beats/min. If the heart rate
during acquisition was 80 beats/min, the patient’s data
were excluded from analysis.
Raw image data sets from all acquisitions were analyzed
by an independent core laboratory. Multisegmental recon-
struction was performed with 0.5-mm slice thickness,
0.3-mm overlap, multiple phases, and electrocardiogram
editing. Images were reconstructed using both standard
(FC43) and sharper (FC05) kernels, particularly used to
reduce artifacts from high-density structures, such as coro-
nary calcification. Two independent, blinded observers,
using a modified coronary model, visually graded each of 19
nonstented segments that were 1.5 mm in diameter,
according to an ordinal scale (no stenosis, 1% to 29%
stenosis, 30% to 49% stenosis, 50% to 69% stenosis, 70% to
99% stenosis, or total occlusion). Then, segments with at
least 1 visible stenosis of 30% were manually quantified
with the use of commercially available software (Vitrea2,
version 3.9.0.1, Vital Images, Minnetonka, Minnesota), and
results for the 2 readers were averaged. Inter-reader visual
and quantitative differences for stenoses 50% were re-
solved by a third observer.
Data acquisition and analysis of data from conventional
coronary angiography. Conventional coronary angiogra-
phy was performed within 30 days after CTA using stan-
dard techniques made uniform across all centers for quan-
titative coronary angiography (QCA). Intracoronary
nitroglycerin was administered (150 to 200 g), and angio-
grams in DICOM (Digital Imaging in Communications in
Medicine) format were transferred to the angiographic core
laboratory. All coronary segments 1.5 mm in diameter
were analyzed quantitatively and visually by blinded readers
using the 29-segment standard model condensed to 19
segments for comparison with data from CTA. Quantitative
coronary angiography of the most severe stenosis was
performed (CAASII QCA Research, version 2.0.1 soft-
ware, Pie Medical Imaging, Maastricht, the Netherlands) in
all nonstented segments. After all measurements from CTA
and conventional coronary angiography were finalized and
stored in the database, a detailed adjudication process was
performed to ensure the correct cross-modality correspondence
of segments (i.e., that the same coronary arterial segments
imaged by means of each method were compared).
Statistical analysis. Data management and statistical anal-
yses were performed in the statistical core laboratory
(Bloomberg School of Public Health) with the use of SAS
software (version 9.1, SAS Institute, Cary, North Carolina), 0Stata software (version 9, StataCorp, College Station,
Texas), and S-PLUS software (version 8.0, Tibco, Palo
Alto, California). Computation of confidence limits for
AUC values for vessel-level data took account of within-
patient clustering through bootstrap resampling, with 2,000
replicate samples. Confidence interval (CI) was calculated
according to the percentile method. All p values of  0.05
were considered to indicate statistical significance. All p
values are 2-sided, and 95% CIs are also presented. In
addition to the results for the entire cohort, analysis was also
performed in subgroups stratified according to pre-test
probability of CAD. For this purpose, patients were allo-
cated a probability score according to Morise et al. (15).
Because no information was available on chest pain charac-
teristics other than typical angina, all symptomatic patients
who did not have typical angina were assumed to have
atypical angina. In addition, a secondary analysis was per-
formed for which noncardiac chest pain was assumed in this
scenario to assess its effect on reclassification.
Results
Of 405 patients who consented, 34 patients were excluded
for technical reasons or because of severe protocol devia-
tions, resulting in a final study population of 371 patients.
Demographics and clinical characteristics of study subjects
are shown in Table 1. Average age was 61  10 years, and
75% were male. The majority of patients had risk factors for
CAD such as arterial hypertension, diabetes mellitus, and
hyperlipidemia. Of 371 study patients, only 3 (0.8%) had a
low pre-test probability for obstructive CAD (all of whom
had a calcium score of 600), whereas 172 (46%) were of
intermediate pre-test probability, and 98 (26%) had a high
pre-test probability for obstructive CAD. Twenty-six per-
cent of patients (n  98) had known CAD. Pre-test
probability for CAD in the subgroup of patients with
calcium score of 600 was intermediate in 26% and high in
35%, and known CAD was present in 39% of patients.
Pre-test probability was intermediate in 52%, high in 24%,
and known CAD was present in 23% of patients with
calcium score 600. On QCA, 163 of 291 (56%) patients
with calcium score 600 had at least 1 obstructive stenosis
of50%, compared to 71 of 80 (89%) patients with calcium
score 600 and 234 of 371 patients (63%) of the entire
cohort. Disease prevalence (50% diameter stenosis by
QCA) was 48% in patients with intermediate and 70% in
patients with high pre-test probability for CAD, and 84%
in patients with known CAD.
Patient-based analysis CT angiography. CT DIAGNOSTIC
ACCURACY COMPARED TO QCA. The area under the
eceiver-operating characteristic curve (AUC) for detecting
50% stenosis by quantitative CTA for the entire cohort
as 0.93 (95% CI: 0.90 to 0.95), which is unchanged from
he AUC reported in patients with calcium score 600
0.93, CI: 0.90 to 0.96) (12). In contrast, the AUC was only
.81 for patients with a calcium score 600 (95% CI: 0.71
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Disease Prevalence Impacts CT Diagnostic Accuracy January 24, 2012:379–87to 0.89, p 0.077, vs.600). The AUC curves, including the
alibration curve for CTA, are shown in Figure 1. The
alibration curve allows assessing CTA performance at differ-
nt thresholds for determining obstructive CAD. For example,
hen using a 45% stenosis threshold for determining CAD by
TA, sensitivity for the entire cohort rises to 92% while
pecificity decreases to 75% (Fig. 1A). The AUC values did
ot differ significantly in patients with intermediate and high
re-test probability (0.93 [95% CI: 0.89 to 0.97] vs. 0.92 [95%
I: 0.85 to 0.96], p  0.70). The AUC for patients with
nown CAD was also similar (0.93 [95% CI: 0.86 to 0.97])
Fig. 1B). Furthermore, the AUC did not change (0.93 [95%
I: 0.90 to 0.96]) for the remaining 273 patients (disease
revalence 55.7%) after excluding patients with known CAD
sensitivity, specificity, and positive and negative predictive
alues and their 95% CIs were 91% [85% to 95%], 87% [79%
o 92%], 90% [84% to 94%], and 88% [81% to 93%]). The
oint statistics for CT diagnostic accuracy according to sub-
Subject CharacteristicsTable 1 Subject Characteristics
All Participants
(n  371)
CACS <600
(n  291)
CACS >
(n 
Age, yrs 61 (53–67) 60 (52–66) 63 (58–
Men 279 (75.2) 214 (73.5) 65 (81.
Race
White 260 (70.1) 196 (67.4) 64 (80.
Black 20 (5.4) 18 (6.2) 2 (2.5
Asian 78 (21.0) 66 (22.7) 12 (15.
Other 13 (3.5) 11 (3.8) 2 (2.5
BMI,* kg/m2 27 (25–30) 27 (25–30) 28 (25–
19 6 (1.6) 6 (2.1) 0 (0)
19–30 276 (74.4) 223 (76.6) 53 (66.
30 89 (24.0) 62 (21.3) 27 (33.
Hypertension 260 (70.1) 192 (66.0) 68 (85.
Diabetes mellitus 97 (26.2) 68 (23.4) 29 (36.
Dyslipidemia 236 (63.6) 175 (60.1) 61 (76.
Smoking
Current 67 (18.1) 56 (19.2) 11 (13.
Past 154 (41.5) 119 (40.9) 35 (43.
Never 150 (40.4) 116 (39.9) 34 (42.
FH CAD 111 (29.9) 74 (25.4) 37 (46.
Previous MI 83 (22.4) 58 (19.9) 25 (31.
Prior PCI 51 (13.8) 28 (9.6) 23 (28.
Angina 212 (57.1) 169 (58.1) 43 (53.
CCS class
0 7 (1.9) 6 (2.1) 1 (1.3
1 40 (10.8) 29 (10.0) 11 (13.
2 128 (34.5) 103 (35.4) 25 (31.
3 24 (6.5) 19 (6.5) 5 (6.3
4 13 (3.5) 12 (4.1) 1 (1.3
CACS 148 (8–478) 80 (1–244) 1,066 (786
Mean  SD 396 623 60.0 8.6 1,325
CTA HR, beats/min 61 (55–69) 62 (55–70) 60 (55–
Values are median (interquartile range) or n (%). *Calculated as weight in kilograms divided by h
BMI body mass index; CACS coronary artery calcium score; CAD coronary artery disease;
R  heart rate; MI  myocardial infarction; n/a  not available; PCI  percutaneous coronary iroups are listed in Table 2.VISUAL CT ASSESSMENT. Visual and quantitative assess-
ents by CTA of stenosis severity were similar (Table 2).
he AUC for the detection of obstructive CAD by visual
ssessment for the entire cohort, the initial group with
alcium score 600, and patients with calcium score 600
ere 0.92, 0.93, and 0.86, respectively (p  0.36, 600 vs.
600 calcium score group), which were not statistically
ignificantly different from quantitative assessment (p 
.135, 600 vs. quantitative CTA).
nalysis according to calcium scores and pre-test probability
f CAD. Table 3 presents the disease prevalence (50%
stenosis by QCA) according to calcium score brackets.
Whereas only 53 of 151 (35%) patients with calcium score
100 had obstructive disease by QCA, 181 of 220 (82%)
patients with calcium score 100 had significant disease. For
patients with calcium score 100 and intermediate pre-test
probability, disease prevalence was only 25% compared to 55%
in patients with high pre-test probability or known CAD (data
Intermediate
Pre-Test Probability
(n  172)
High
Pre-Test Probability
(n  98)
Known CAD
(n  98)
58 (52–65) 63 (58–71) 63 (55–68)
121 (70.4) 78 (79.6) 80 (81.6)
119 (69.2) 71 (72.5) 68 (69.4)
9 (5.2) 3 (3.1) 7 (7.1)
37 (21.5) 21 (21.4) 20 (20.4)
7 (4.1) 3 (3.1) 3 (3.1)
27 (25–30) 28 (25–32) 27 (24–31)
3 (1.7) 1 (1.0) 2 (2.0)
139 (80.8) 63 (64.3) 71 (72.5)
30 (17.4) 34 (34.7) 25 (25.5)
100 (58.1) 91 (92.9) 67 (68.4)
17 (9.9) 45 (45.9) 35 (35.7)
82 (47.7) 82 (83.7) 71 (72.5)
28 (16.3) 17 (17.4) 21 (21.4)
63 (36.6) 44 (44.9) 46 (46.9)
81 (47.1) 37 (37.8) 31 (31.6)
39 (22.7) 35 (35.7) 36 (36.7)
n/a n/a 83 (84.7)
n/a n/a 51 (52.0)
76 (44.2) 86 (87.8) 50 (51.0)
4 (2.3) 2 (2.0) 1 (1.0)
11 (6.4) 18 (18.4) 11 (11.2)
48 (27.9) 52 (53.1) 28 (28.6)
9 (5.2) 11 (11.2) 4 (4.1)
4 (2.3) 3 (3.1) 6 (6.1)
9) 49 (0–337) 251(65–653) 303 (106–764)
263 473 515 756 522 669
62 (55–68.5) 62 (55–70) 60 (55–67)
meters squared.
Canadian Cardiovascular Society; CTA computed tomography angiography; FH family history;
tion.600
80)
70)
3)
0)
)
0)
)
32)
3)
8)
0)
3)
3)
8)
8)
5)
3)
3)
8)
8)
)
8)
3)
)
)
–1,53
781
67)
eight inwere combined since they are similar in characteristics). For
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January 24, 2012:379–87 Disease Prevalence Impacts CT Diagnostic Accuracypatients with calcium score 100, disease prevalence was
similarly high for patients with intermediate and high pre-test
probability/known CAD (77% vs. 85%).
To assess the effect of coronary calcification on positive
and negative predictive values, we separately analyzed data
according to absent, mild, moderate, and severe calcification
and pre-test probability (Fig. 2). Positive predictive values
were very good (88% to 98%) and negative predictive values
were poor (50% to 64%) for patients with high pre-test
probability/known CAD and any coronary calcification
(calcium score 0). Only 20 of 196 (10%) patients with
high pre-test probability/known CAD had no coronary
calcification, and both positive and negative predictive
values were excellent for these patients (100% and 93%,
respectively). Among patients with intermediate pre-test
probability, positive predictive values were modest (60% to
80%), and negative predictive values (91% to 96%) were
excellent only with low calcium scores (0 to 99) whereas
positive predictive values were very good (90% to 93%) and
negative predictive values were poor (71% to 78%) with
moderate and severe coronary calcification (calcium scores
100 to 399 and 400) (Fig. 2). When combining data into
2 groups, negative predictive value in patients with inter-
mediate pre-test probability was 93% for a calcium score of
0 to 99 and 75% for a calcium score 100 (p  0.053).
Because we assumed patients with nonanginal chest pain to
have atypical rather than noncardiac chest pain, we may
have classified some patients into a higher pre-test proba-
bility category. If we assumed noncardiac chest pain instead,
10 patients would have been reclassified from high to
intermediate, and 17 from intermediate to low pre-test
probability. The reclassifications did not result in different
diagnostic accuracy for the groups: for 165 patients with
intermediate pre-test probability and 50.3% disease preva-
lence, sensitivity, specificity, positive and negative predictive
values, and AUC including their 95% CIs were 89% (80% to
95%), 85% (76% to 92%), 86% (77% to 93%), 89% (79% to
95%), and 0.93 (0.88% to 0.96%). For 88 patients with high
pre-test probability and 70.5% disease prevalence sensitivity,
specificity, positive and negative predictive values, and AUC
including their CIs were 92% (82% to 97%), 85% (65% to
96%), 93% (84% to 98%), 81% (62% to 94%), and 0.92
(0.84% to 0.97%). For 20 patients with low pre-test prob-
ability after reclassification (disease prevalence of 35%),
sensitivity, specificity, positive and negative predictive val-
ues, and AUC including their lower CIs were 100% (59%),
100% (75%), 100% (59%), 100% (75%) and 1.00 (0.83%).
Figure 3 illustrates the dependency of predictive values on
disease prevalence in the study population.
Discussion
The main results of this investigation can be summarized as
follows. 1) Despite poorer performance in patients with
severe coronary calcification, inclusion of such patients didFigure 1 ROC Curves for CTA Diagnostic Accuracy
According to Calcium Scores and Pre-Test Probability
(A) Receiver-operating characteristic (ROC) curves for all patients (solid line),
patients with calcium score 600 (dotted line), and patients with calcium
score 600 (dashed line), describing the diagnostic performance of quantitative
multidetector (MD) computed tomography angiography (CTA) to identify a 50%
coronary arterial stenosis in a patient when compared to quantitative coronary
angiography (QCA). The light gray line is a calibration curve; to identify the corre-
sponding CTA threshold point, extend a vertical line from a point on the ROC curve
to the calibration curve and then a horizontal line to the right ordinate, which gives
the CTA threshold. For example, a sensitivity of 88% and a false positive rate
(1-specificity) of 13% correspond to a threshold point of 50% stenosis detected by
CTA. The area under the curve (AUC) was 0.93 for all patients, 0.93 for patients
with calcium score 600, and 0.80 for patients with calcium score 600 (p 
0.063 vs. score 600). (B) The ROC curves for patients with intermediate pre-test
probability of coronary artery disease (solid line), high pre-test probability (dashed
line), and known coronary artery disease (dotted line). The area under the curve
(AUC) was 0.93 for patients with intermediate pre-test probability of coronary artery
disease, 0.92 for patients with high pre-test probability, and 0.93 for patients with
known coronary artery disease.not alter the overall test performance of CTA to detect a
graphy;
o
a
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Disease Prevalence Impacts CT Diagnostic Accuracy January 24, 2012:379–8750% stenosis in the CORE-64 multicenter study. 2) The
diagnostic accuracy for CTA to detect obstructive CAD was
reduced in patients with severe coronary calcification (cal-
cium score of 600) compared to patients with a calcium
score 600. 3) Pre-test probability of CAD and coronary
calcium score markedly affect negative predictive values for
detecting obstructive CAD by CTA. 4) Noninvasive coro-
nary angiography using CT best rules out obstructive CAD
in patients with low-intermediate pre-test probability of
CAD and mild coronary calcification or in patients with
a calcium score of zero.
CTA diagnostic accuracy. Compared to 2 other multi-
center studies using 64-slice technology, our results revealed
slightly lower sensitivity but higher specificity for detecting
obstructive CAD by CTA, suggesting a higher reader
threshold to call a given stenosis obstructive (7,16). When
combined with a relatively higher prevalence of obstructive
CAD, positive predictive values were higher but negative
predictive values were lower compared to other multicenter
studies (7,16). A unique feature of the CORE-64 study is
the use of continuous quantitative CTA data in addition to
semiquantitative assessment, which allows assessing CTA
performance with greater independence from reader bias.
For example, if a more conservative approach was chosen,
Diagnostic Accuracy of CTA for Detecting >50% Coronary ArterialTable 2 Diagnostic Accuracy of CTA for Detecting >50% Coron
n CAD Sensitivity
Quantitative CTA, all 371 63.1% 0.88 (0.83–0.92)
Quantitative CTA, 600 291 56.0% 0.85 (0.79–0.90)
Quantitative CTA, 600 80 88.8% 0.94 (0.86–0.98)
Quantitative CTA, without known CAD 273 55.7% 0.91 (0.85–0.95)
Visual CTA, all 371 63.1% 0.85 (0.80–0.89)
Visual CTA, calcium 600 291 56.0% 0.83 (0.76–0.88)
Visual CTA, calcium 600 80 88.8% 0.96 (0.88–0.99)
Quantitative CTA, intermed PTP 172 47.7% 0.89 (0.80–0.95)
Quantitative CTA, high PTP 98 70.4% 0.93 (0.84–0.98)
Quantitative CTA, known CAD 98 83.7% 0.83 (0.73–0.90)
Values are presented for all patients, patients with calcium score600, patients with calcium score
the 95% confidence intervals.
AUC area under the curve; CAD coronary artery disease; CTA computed tomography angio
pre-test probability.
Distribution of Calcium Scoresand Associated Disease PrevalencesTable 3 Distribution of C lcium Scoresand Associated Disease Prevalences
Calcium Score All
Intermediate
Risk
High Risk or
Known CAD
0 72 (14, 58) 50 (7, 43) 20 (7, 13)
1–99 79 (39, 40) 47 (17, 30) 31 (21, 10)
100–199 52 (36, 16) 19 (15, 4) 33 (21, 12)
200–299 29 (25, 4) 11 (9, 2) 18 (16, 2)
300–399 32 (27, 5) 9 (5, 4) 23 (22, 1)
400–499 18 (14, 4) 11 (10, 1) 7 (4, 3)
500–599 9 (8, 1) 4 (3, 1) 5 (5, 0)
600 80 (71, 9) 21 (16, 5) 59 (55, 4)
Given are the number of patients in each calcium score bracket ( and symbols indicate number
f positive and negative findings by quantitative coronary angiography defined as 50% coronary
rterial stenosis).
CAD  coronary artery disease.namely, a lower threshold to call a stenosis significant such
as typically employed in clinical practice, sensitivity for the
entire cohort would increase from 88% to 94% for a 40%
stenosis threshold, at the expense of specificity, which would
decrease from 87% to 64% (Fig. 1). These results are almost
osisrterial Stenosis
Specificity PPV NPV AUC
7 (0.80–0.92) 0.92 (0.88–0.95) 0.81 (0.74–0.87) 0.93 (0.90–0.95)
0 (0.83–0.94) 0.91 (0.86–0.95) 0.83 (0.75–0.89) 0.93 (0.90–0.96)
4 (0.14–0.79) 0.93 (0.85–0.98) 0.50 (0.16–0.84) 0.81 (0.71–0.89)
7 (0.79–0.92) 0.90 (0.84–0.94) 0.88 (0.81–0.93) 0.93 (0.90–0.96)
0 (0.83–0.94) 0.93 (0.89–0.96) 0.78 (0.73–0.87) 0.92 (0.89–0.95)
1 (0.85–0.96) 0.92 (0.87–0.96) 0.81 (0.71–0.85) 0.92 (0.89–0.95)
6 (0.21–0.86) 0.94 (0.86–0.98) 0.63 (0.24–0.91) 0.86 (0.77–0.93)
8 (0.79–0.94) 0.87 (0.78–0.93) 0.90 (0.81–0.95) 0.93 (0.89–0.97)
3 (0.64–0.94) 0.93 (0.84–0.98) 0.83 (0.64–0.94) 0.92 (0.85–0.96)
8 (0.62–0.98) 0.97 (0.90–1.00) 0.50 (0.31–0.69) 0.93 (0.86–0.97)
patients with intermediate pre-test probability, high pre-test probability, and known CAD, including
intermed intermediate; NPV negative predictive value; PPV positive predictive value; PTP
Figure 2 Predictive Values According to Pre-Test Probability
and Presence/Extent of Coronary Calcification
Shown is a plot of positive predictive values (solid bars) and negative predic-
tive values (open bars) for (A) patients with intermediate pre-test probability of
coronary artery disease (n  172), and (B) patients with either high pre-test
probability or known coronary artery disease (n  196 combined), grouped into
patients without calcification (calcium score 0) and with mild calcification
(score 1 to 99), moderate calcification (score 100 to 399), and severe coro-
nary calcification (score 400).Stenary A
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in a comparable population (16), demonstrating consistency
of CTA accuracy results if methodology and patient char-
acteristics are considered. However, comparison of our
results to the ACCURACY (Assessment by Coronary
Computed Tomographic Angiography of Individuals Un-
dergoing Invasive Coronary Angiography) multicenter
study (7) is difficult because its disease prevalence and
patient population were markedly different from ours. Nev-
ertheless, the reported AUC, which depends only on sen-
sitivity and specificity, of 0.96 (95% CI: 0.94 to 0.98) was
similar to what we found in our study.
In our study, we demonstrate that predictive values
critically depend on the disease prevalence in the study
population. With rising disease prevalence, positive predic-
tive values increase while negative predictive values decrease.
Thus, general statements regarding the positive or negative
predictive value of CTAs or any other tests should be
avoided, as even a test with high sensitivity and specificity
displays a remarkable variability for predictive values within
a clinically applicable range of disease prevalence (Fig. 3).
Rather, the predictive value of a diagnostic test has to be
seen in the context of the study population and should be
applied accordingly. Both pre-test probability and calcium
score identify patients of different disease prevalence and
may help recognizing the most adequate clinical scenario for
the use of CTA.
Impact of severe coronary arterial calcification on CTA
performance. Previous investigations have come to differ-
nt conclusions with regard to whether severe coronary
rterial calcification hampers CTA diagnostic performance.
Figure 3 Predictive Values of a Diagnostic Test
According to Disease Prevalence
Shown are positive predictive values (solid line) and negative predictive values
(dashed line) as a function of disease prevalence, ranging from 0% to 100%
for a diagnostic test with a sensitivity and specificity of 90%, chosen as arbi-
trary but typical values. The reference line indicates the disease prevalence
observed in this study (63%). One can appreciate the large shifts in predictive
values according to low versus high disease prevalence.everal groups reported the same or better performance inpatients with high calcium scores compared to patients with
less calcification, whereas others found poorer performance
in the former (6–9). Our results revealed reduced CTA
accuracy to detect obstructive CAD in patients with severe
coronary calcification (600 calcium score) that was pre-
dominantly the result of markedly poorer specificity while
sensitivity actually improved. The poor specificity was
driven by the high disease prevalence of 89% in this
subgroup—only 9 of 80 patients did not have obstructive
CAD by QCA. Accordingly, the negative predictive value
was low while the positive predictive value was excellent.
Therefore, CTA is ineffective for ruling out coronary
arterial stenoses in patients with severe coronary calcifica-
tion who were referred for invasive angiography because of
clinical suspicion of significant CAD.
Impact of pre-test probability on CTA diagnostic accuracy.
Because predictive values are substantially influenced by the
disease prevalence in the studied population, we separated
our population by pre-test probability for obstructive CAD.
While overall test accuracy did not vary significantly among
patients with intermediate and high pre-test probability and
patients with known CAD, which was largely because of
balanced shifts in sensitivity and specificity, negative pre-
dictive value was higher in patients with intermediate
pre-test probability than in other subgroups as disease
prevalence was lower. If the purpose of CTA is to exclude
obstructive CAD, a high negative predictive value is desired
while a less than optimal positive predictive value may be
acceptable. In patients with intermediate pre-test probabil-
ity, remarkably, both positive and negative predictive values
were very good in our study, with 87% and 90%, respec-
tively. Our results reveal little about the use of CTA in
patients with low pre-test probability as they were poorly
represented in our population. As predictive values are a
function of a test’s sensitivity and specificity for a given
disease prevalence, we can confidently state that the negative
predictive value would exceed 95% for patients with low
pre-test probability (20%) using CORE-64 study data,
confirming results of other studies documenting a high
negative predictive value in a population that appears most
applicable to the use of CTA at present. Our secondary
analysis of 20 patients of low-intermediate pre-test proba-
bility and 35% disease prevalence yielding a negative pre-
dictive value of 100% supported this notion. Conversely, our
results confirm current recommendations to omit CTA for
excluding obstructive CAD in patients with high pre-test
probability for CAD, with the possible exception of patients
with zero calcium score, who were, however, a minority
(10%) within this group.
Is there a calcium score threshold beyond which CTA is
not effective? Currently, the primary clinical value of CTA
is perceived to be its ability to conclusively rule out obstruc-
tive CAD in patients of low-intermediate pre-test proba-
bility with equivocal test results and atypical symptoms
(1,2). Because the probability of obstructive CAD increases
with the coronary calcium score, some clinicians withhold
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(11). The coronary calcium score threshold beyond which
CTA is deemed unnecessary, however, is controversial. Our
analysis reveals that negative predictive values were 90% and
greater in patients with intermediate pre-test probability for
CAD but not more than mild coronary calcification, as well
as in patients with any pre-test probability and a calcium
score of zero. Conversely, negative predictive value for CTA
as highly variable and on average poor in patients with high
re-test probability and known CAD with any coronary
alcification, as well as in patients with intermediate pre-test
robability for CAD and more than mild coronary calcification
Fig. 2). A coronary calcium score of100 in patients referred
for cardiac catheterization with clinical suspicion of CAD,
therefore, identified patients who are very likely to have
obstructive CAD and in whom CTA is less effective in ruling
out disease. Conversely, the absence of coronary calcification is
insufficient to dismiss the possibility of obstructive CAD (17),
and CTA is highly effective in excluding significant coronary
arterial stenoses in such patients.
Study limitations. Although we attempted to provide a
comprehensive characterization of our patient population,
our data are incomplete. We attempted to characterize the
patient population using an established CAD pre-test prob-
ability score, but some factors influencing post-test proba-
bility may not have been accounted for. Our results, there-
fore, may represent a conservative assessment of the utility
of CTA in the presence of coronary calcification. Further-
more, we cannot provide data on how many patients were
screened but not included in this cohort. Lastly, our patient
population is international and not necessarily representa-
tive of a North American population per se.
Consistent with current guidelines (1,2), statements with
regard to the clinical usefulness of CTA are being made
with respect to its ability to detect, and particularly to rule
out, obstructive CAD. Moreover, CTA is capable of pro-
viding information about lesion location, plaque character-
istics, remodeling status, and other features, which may
prove to be useful for clinical management of patients in
selected situations. Therefore, while the accuracy of CTA to
merely detect obstructive disease may be reduced compared
to conventional angiography in patients with severe coro-
nary calcification or high pre-test probability, additional
CAD assessment may outweigh this “deficiency.” This
hypothesis is being tested in current investigations.
Although it would be desirable from a clinical standpoint to
identify a calcium score “threshold” beyond which CTA is
considered not useful, it has to be emphasized that such a
threshold does not exist. Rather, there is a continuous shift
from what one may consider an effective test to a less effective
one, with uncertainty of test performance in the transition
zone. Therefore, as with all diagnostic test modalities, clini-
cians should interpret the calcium score in the greater context
for guidance of how to interpret the CTA rather than making
binary decisions based on particular score thresholds.Lastly, some of the secondary analyses contained in this
investigation contained relatively small numbers, and results
must be interpreted with caution.
Conclusions
The ability of a diagnostic test to predict or to exclude
disease is critically dependent not only on its sensitivity and
specificity but also on the disease prevalence within the
study population. Accordingly, our results demonstrate that
pre-test probability for CAD and coronary calcium score,
which are both predictive of disease prevalence, are impor-
tant for the effectiveness of CTA to exclude or confirm the
presence of obstructive CAD in patients. Computed to-
mography angiography accurately rules out obstructive
CAD in patients with low or intermediate pre-test proba-
bility who have low coronary calcium scores as well as in
patients with any pre-test probability and a calcium score of
zero. Conversely, CTA is less effective for this purpose in
patients with high pre-test probability, known CAD, and
patients with extensive coronary calcification. In patients
with clinical suspicion of CAD sufficient to consider cardiac
catheterization, moderate or severe coronary calcification
alone is highly predictive of obstructive CAD.
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